Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP11B1 | P15538 | 1/20 | 0.36 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 2/20 | 0.33 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13488023 | 0.94 | CYP11B1 (0.36) | CYP11B1CYP11B2MEN1MAPTKMT2A | |
| SCHEMBL13487646 | 0.94 | MEN1 (0.33) | CYP11B1CYP11B2MEN1MAPTKMT2A | |
| SCHEMBL13487227 | 0.92 | CYP11B1 (0.35) | CYP11B1CYP11B2MEN1MAPTKMT2A | |
| SCHEMBL13487699 | 0.91 | AKT1 (0.35) | CYP11B1CYP11B2MEN1MAPTKMT2A | |
| SCHEMBL13487623 | 0.90 | MEN1 (0.32) | CYP11B1CYP11B2MEN1MAPTKMT2A | |
| SCHEMBL13487578 | 0.89 | HSD17B3 (0.36) | KMT2A | |
| SCHEMBL13487821 | 0.89 | CHEK1 (0.31) | — | |
| SCHEMBL13487648 | 0.89 | MEN1 (0.36) | CYP11B1CYP11B2MEN1MAPTKMT2A | |
| SCHEMBL13487647 | 0.89 | MEN1 (0.36) | MEN1MAPTKMT2AKDM4EMAPK1 | |
| SCHEMBL13488014 | 0.89 | MEN1 (0.33) | CYP11B1CYP11B2MEN1MAPTKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100045170-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2010-02-25 | — | — | US | disclosed |
| US-20100045170-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2010-02-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100045170-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | OCIAD1, OCIAD2, ORMDL3 | CYP11B1 492/4885CYP11B2 548/4885MEN1 3017/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.